Context Therapeutics Inc (CNTX) Stock Price, Quote, News & History

CNTXNASDAQ
$0.4699
0.00410.88%
At close: Aug 11, 5:00 PM EST
$0.4700
0.00420.9%
Pre-Market: 4:00 AM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-33.97M
Investing Cash Flow (TTM)
-6.56M
Financing Cash Flow (TTM)
0
Free Cash Flow (TTM)
-40.53M
Capital Expenditure (TTM)
-6.56M
Net Change in Cash (TTM)
-40.53M

Analyst Trends and Forecast

3
Mar
1
Jun
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$428.65K
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.13
Earnings Yield % (TTM)
-102.15%
Earnings Yield % (FWD)
-92.57%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.42

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$42.99M
Debt to Equity
0.01
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$0.47
Volume / Avg.
75.00 / 2.48M
Day Range
- - -
52 Wk Range
0.43 - 3.62
Market Cap
$43.18M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
33
Short Interest
7.32%
Days to Cover
4.23

About

Sector
Health Care
Industry
Pharmaceuticals
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, includin...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Context Therapeutics (CNTX) stock?

A

You can purchase shares of Context Therapeutics (NASDAQ:CNTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Context Therapeutics (CNTX) competitors?

Q

What is the forecast, or price target, for Context Therapeutics (CNTX) stock?

A

Context Therapeutics has a consensus price target of $5.69.

Q

What is the current price for Context Therapeutics (CNTX)?

A

The stock price for Context Therapeutics (NASDAQ: CNTX) is $0.47 last updated August 12, 2026 at 7:42 PM EDT.

Q

Does Context Therapeutics (CNTX) pay a dividend?

A

There are no upcoming dividends for Context Therapeutics.

Q

When is Context Therapeutics (NASDAQ:CNTX) reporting earnings?

A

Context Therapeutics does not have any upcoming earnings scheduled.

Q

Is Context Therapeutics (CNTX) going to split?

A

There is no upcoming split for Context Therapeutics.

Q

What sector and industry does Context Therapeutics (CNTX) operate in?

A

Context Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.